A detailed history of Bank Of America Corp transactions in Ironwood Pharmaceuticals Inc stock. As of the latest transaction made, Bank Of America Corp holds 712,387 shares of IRWD stock, worth $3.53 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
712,387
Previous 906,289 21.4%
Holding current value
$3.53 Million
Previous $7.89 Million 41.16%
% of portfolio
0.0%
Previous 0.0%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$5.58 - $8.61 $1.08 Million - $1.67 Million
-193,902 Reduced 21.4%
712,387 $4.64 Million
Q1 2024

May 15, 2024

BUY
$8.32 - $15.45 $1.83 Million - $3.39 Million
219,523 Added 31.96%
906,289 $7.89 Million
Q4 2023

Feb 14, 2024

SELL
$8.79 - $11.51 $444,000 - $581,393
-50,512 Reduced 6.85%
686,766 $7.86 Million
Q2 2023

Aug 14, 2023

SELL
$10.1 - $11.6 $3.22 Million - $3.7 Million
-318,831 Reduced 30.19%
737,278 $7.84 Million
Q1 2023

May 12, 2023

BUY
$10.37 - $12.56 $1.28 Million - $1.54 Million
122,998 Added 13.18%
1,056,109 $11.1 Million
Q4 2022

Feb 10, 2023

BUY
$9.9 - $12.43 $2.8 Million - $3.52 Million
283,011 Added 43.53%
933,111 $11.6 Million
Q3 2022

Nov 14, 2022

BUY
$10.14 - $12.38 $2.59 Million - $3.16 Million
255,130 Added 64.59%
650,100 $6.73 Million
Q2 2022

Aug 12, 2022

SELL
$11.05 - $12.72 $2.26 Million - $2.6 Million
-204,364 Reduced 34.1%
394,970 $4.55 Million
Q1 2022

May 16, 2022

SELL
$10.61 - $12.88 $212,688 - $258,192
-20,046 Reduced 3.24%
599,334 $7.54 Million
Q4 2021

Feb 08, 2022

BUY
$10.86 - $13.95 $2.35 Million - $3.02 Million
216,160 Added 53.61%
619,380 $7.22 Million
Q3 2021

Nov 15, 2021

BUY
$11.92 - $13.92 $200,518 - $234,162
16,822 Added 4.35%
403,220 $5.27 Million
Q2 2021

Sep 13, 2021

BUY
$10.16 - $13.11 $3.93 Million - $5.07 Million
386,398 New
386,398 $4.97 Million

Others Institutions Holding IRWD

About IRONWOOD PHARMACEUTICALS INC


  • Ticker IRWD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 153,231,008
  • Market Cap $760M
  • Description
  • Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZE...
More about IRWD
Track This Portfolio

Track Bank Of America Corp Portfolio

Follow Bank Of America Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of America Corp with notifications on news.